NewsSource: EClinCloud

EClinCloud Product Overview | RTSM: Randomization and Trial Supply Management System

2 min readEClinCloud Editorial Team
EClinCloud Product Overview | RTSM · Randomization and Trial Supply Management System news header image

Source: EClinCloud. Author: EClinCloud.

EClinCloud · Clinical Research AI Technology Company

RTSM · Randomization and Trial Supply Management System

Flexible Randomization · Agile Configuration · Multi-Protocol Support

Randomization and trial supply management (RTSM) handles randomization, trial drug supply, and inventory management, serving as a key system for ensuring standardized study execution and supply chain stability.

EClinCloud RTSM supports flexible randomization designs, medication management, and more, helping sponsors achieve more scientific, efficient, and compliant randomization and trial drug management.

01  Product Overview

The EClinCloud RTSM (Randomization and Trial Supply Management) system represents an advanced web-based randomization and drug supply management platform for multicenter clinical trials. Designed with a risk-based approach and integrating AI, the system efficiently manages large-scale, multicenter clinical trials running multiple protocols in parallel, helping investigators implement diverse study models including complex randomization schemes and trial designs. Through the EClinCloud platform, investigators can control trial workflows more precisely, ensure smooth trial conduct, and improve drug management and utilization.

02  What We Can Offer You

■ RTSM System

■ System Configuration Services

■ Randomization and Blinding Services

■ Drug Supply Management Services

03  AI-Driven RTSM Intelligent Upgrade

AI-Automated Rapid Study Build

Automatically parses trial protocols and randomization requirements to complete RTSM configuration in one click, flexibly adapting to complex trial designs, improving configuration efficiency, and accelerating study startup.

For more AI capabilities, contact us to learn more...

04  Why Choose EClinCloud RTSM

■ Clean interface and clear workflows that adapt to changing protocol requirements and improve efficiency

■ High system adaptability and flexibility, enabling seamless integration with different systems and data interoperability

■ Full-lifecycle drug management and intelligent alerts to control risks, providing a comprehensive solution for medication management

■ Automated and standardized processes that enhance the authenticity and credibility of study data

05  Value Proven in Client Practice

Case Study: Providing Digital Support for a National Major Project Study

EClinCloud RTSM supports randomization and trial drug management for a National Science and Technology Major Project study, meeting multicenter collaborative research needs and achieving study data standardization, end-to-end quality control, and study process traceability.

Integrated Platform · Interconnected Data

RTSMCTMSeTMFEDCeCOARMIRCeLearningScale managementRater training

📞 Contact us

Website: www.eclincloud.com

Email: ecc@eclincloud.com

Technological innovation to bring effective treatments to patients





About EClinCloud


EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it builds an integrated clinical intelligence cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient and precise digital solutions. Leveraging AI predictive models and an intelligent data platform, EClinCloud dynamically evaluates and helps improve drug clinical trial success rates, helping shorten drug/device development cycles to benefit patients.







Article illustration

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.